tiprankstipranks
Advertisement
Advertisement

JP:4883 Stock Latest News

Modalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
Company AnnouncementsModalis Books ¥14 Million in FX Gains, Boosting Quarterly Results
1d ago
4883
Modalis outlines conditions and limitations around its Q1 2026 disclosure
PremiumCompany Announcements
Modalis outlines conditions and limitations around its Q1 2026 disclosure
1d ago
4883
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
PremiumCompany Announcements
Modalis Narrows Quarterly Loss but Keeps Outlook Uncertain Amid Zero Revenue
1d ago
4883
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
PremiumCompany Announcements
Modalis Sells Idle U.S. Equipment, Books Extraordinary Gain on Asset Transfer
17d ago
4883
Modalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
PremiumCompany Announcements
Modalis Sets Terms for 18th Stock Option Plan, Issuing 935,000 Potential Shares
1M ago
4883
Modalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
PremiumCompany AnnouncementsModalis Therapeutics Issues 18th Series Stock Options to Align Incentives and Retain Talent
2M ago
4883
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
Premium
Company Announcements
Modalis Outlines FY2025 Growth Plans in Confidential TSE-Mandated Update
2M ago
4883
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
Premium
Company Announcements
Modalis Therapeutics Seeks Approval for Virtual-Ready Shareholder Meetings
3M ago
4883
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
PremiumCompany Announcements
Modalis to Wipe Out Retained Earnings Deficit via Capital Reduction
3M ago
4883
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
PremiumCompany Announcements
Modalis Slows IND Timeline for Lead CRISPR Program as It Strengthens Clinical Readiness
3M ago
4883
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
PremiumCompany Announcements
Modalis Loss Widens on Higher R&D Spend Amid Zero Revenue in FY2025
3M ago
4883
Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
PremiumCompany Announcements
Modalis Books Foreign Exchange Gain for FY2025 on Currency Revaluation
3M ago
4883
Modalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
PremiumCompany AnnouncementsModalis Issues FY2025 Report With Strict Confidentiality and Risk Disclaimers
3M ago
4883
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
Premium
Company Announcements
Modalis posts wider losses in 2025, with no revenue and no 2026 guidance
3M ago
4883
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
Premium
Company Announcements
Modalis Therapeutics Issues New Shares for Employee Incentive Plan
6M ago
4883
Modalis Therapeutics Reports Foreign Exchange Loss
PremiumCompany Announcements
Modalis Therapeutics Reports Foreign Exchange Loss
6M ago
4883
Modalis Therapeutics Reports Increased Losses and Decline in Financial Position
PremiumCompany Announcements
Modalis Therapeutics Reports Increased Losses and Decline in Financial Position
6M ago
4883
Modalis Therapeutics Announces Key Executive Appointments
PremiumCompany Announcements
Modalis Therapeutics Announces Key Executive Appointments
8M ago
4883
Modalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings
PremiumCompany Announcements
Modalis Therapeutics Reports Foreign Exchange Loss Impacting Earnings
9M ago
4883
Modalis Therapeutics Reports Financial Results for H1 2025
PremiumCompany AnnouncementsModalis Therapeutics Reports Financial Results for H1 2025
9M ago
4883
Modalis Therapeutics Issues New Shares for Employee Compensation
Premium
Company Announcements
Modalis Therapeutics Issues New Shares for Employee Compensation
10M ago
4883
Modalis Therapeutics Partners with Broad Institute for Gene Therapy Advancement
Premium
Company Announcements
Modalis Therapeutics Partners with Broad Institute for Gene Therapy Advancement
10M ago
4883

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >